Benjamin Fand,  MD

Dr. Benjamin Fand completed his undergraduate degree at Princeton University. He received his Doctor of Medicine from Rutgers Medical School in New Jersey. He then went on to his Urologic Internship and Residency at Montefiore Medical Center, Albert Einstein School of Medicine in New York. Additionally, he underwent urological oncology surgical training at Memorial Sloan Kettering in New York City.

Board certified in urology and a Fellow of the American College of Surgeons, Dr. Fand joined Urological Surgical Associates in 1984. Dr. Fand’s area of surgical specialty interest includes prostate cancer therapy with the implantation of intraprostatic radioactive seeds, stone disease surgical therapies and minimally invasive treatments of BPH, including laser prostatectomy and water vapor ablation.

Dr. Fand has also served as the New Jersey representative on the New York section AUA Board of Directors, as an executive board member of the NJ Patient Care and Access Coalition, as a member of the Operating Committee at the New Jersey Kidney Stone Center and as a managing partner of Premier Urology Group. He was also a sub-investigator for a national clinical trial on chemo-prevention monitoring the progression of prostatic intra-epithelial neoplasia (PIN) to prostate cancer.